Yahoo Web Search

Search results

    • AbbVie (ABBV) Q1 2024 Earnings Call Transcript

      AbbVie (ABBV) Q1 2024 Earnings Call Transcript

      Motley Fool via Yahoo Finance· 3 hours ago

      We also gained U.S. approval of Juvederm Voluma XC for temple hollows, further strengthening our leadership in aesthetic fillers, and we executed several...

    • AbbVie Reports First-Quarter 2024 Financial Results

      WSYR 9 Syracuse· 11 hours ago

      ...Percent on a Reported Basis, or 2.5 Percent on an Operational Basis; Global Botox Cosmetic Net Revenues Were $633 Million; Global Juvederm Net Revenues Were $297 MillionSuccessfully Completed Acquisition of ImmunoGen and its Flagship Cancer Therapy, ElahereRaises 2024 Adjusted...

    • The Ultimate Guide to Big Data Strategy

      The Ultimate Guide to Big Data Strategy

      TechBullion· 4 days ago

      The sheer volume, velocity, and variety of data – commonly referred to as ‘big data’ – present both unprecedented opportunities and unprecedented...